Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC).
conference contribution
posted on 2015-05-20, 00:00authored byMustafa Khasraw, Violet Rudo Mukaro, Linda West, Conrad Brandt, Anne Maree Woollett, Michelle Edwards, Robert Spokes, Gregory Mitchell, Kimberley Prince, Theresa M Hayes, Ian CollinsIan Collins, Alexander David Guminski, Sally E Baron-Hay, Inger Helen Olesen, Jacinta Bryan, Susan Bowles, Shu Fen Wong, David M Ashley, Sujata Patil
Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC).
History
Volume
33
Pagination
e12025-e12025
Location
Chicago, Ill.
Start date
2015-05-29
End date
2015-06-02
ISSN
0732-183X
eISSN
1527-7755
Language
eng
Publication classification
E3.1 Extract of paper
Title of proceedings
ASCO 2015 : Illumination adn innovation transforming data into learning : Proceedings of American Society of Clinical Oncology 2015 conference
Event
American Society of Clinical Oncology. Conference (2015 : Chicago, Ill.)